News Search Results
May 22, 2026, 10:30 ET How Hyperlink InfoSystem is Enhancing Project Delivery with Improved Communication and Agile Processes
Building,122 Leadenhall Street,London EC3V 4ABCanada Address:151 Yonge Street, 11th Floor,Toronto, Ontario, M5C 2W7,CanadaLogo: https://mma.prnewswire.com/media/2429933/5421426/Hyperlink_InfoSystem_Logo.jpg
More news about: Hyperlink InfoSystem
May 22, 2026, 10:22 ET Teksański Instytut Arytmii Serca przy Centrum Medycznym St. David's będzie gospodarzem międzynarodowej konferencji poświęconej złożonym zaburzeniom rytmu serca
ekspertów z nowoczesnego Centrum Elektrofizjologii w St. David's Medical Center, będą stanowiły podstawowe narzędzie dydaktyczne. „EPLive 2026 stanowi wyjątkową okazję dla światowej społeczności elektrofizjologicznej do wspólnego uczestnictwa w nauce w czasie rzeczywistym poprzez edukację opartą na
More news about: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center
May 22, 2026, 08:38 ET ChillerOne Installs Water-Cooled Screw Chiller in Pepsi Cola in the Philippines
production costs."The Model TPW-350WDH chiller systems use R407C refrigerant, and can achieve operating energy efficiency (EER) of up to ~4.4–4.8 W/W with high part-load efficiency. It has a glycol-chilled water temperature system and a waterproof design for outdoor installation.For more information
More news about: ChillerOne Co., Ltd.
May 22, 2026, 08:30 ET Caris Life Sciences to Present 32 Studies at ASCO 2026 Highlighting Advances in Multi-omic Biomarker Research and Real-World Evidence
George W. Sledge, Jr., MD. "The breadth of research being presented at ASCO reflects the importance of comprehensive molecular profiling and data-driven discovery
More news about: Caris Life Sciences
May 22, 2026, 05:45 ET TUESDAY INVESTOR DEADLINE: Super Micro Computer, Inc. (SMCI) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
offices. Contact: Robbins Geller Rudman & Dowd LLP Ken Dolitsky Michael Albert 655 W. Broadway, Suite 1900, San Diego, CA 92101 800/851-7783 [email protected]
More news about: Robbins Geller Rudman & Dowd LLP
May 22, 2026, 05:00 ET Hisense wprowadza serię UR8 z naturalnym i wiernym odwzorowaniem kolorów, czyniąc technologię RGB MiniLED nowej generacji dostępną dla kolejnych gospodarstw domowych
premium.HisenseFirma Hisense powstała w 1969 r., a obecnie jest liderem światowego rynku urządzeń RTV/AGD i elektroniki użytkowej z oddziałami w ponad 160 państwach. Hisense specjalizuje się w wysokiej klasy produktach multimedialnych, urządzeniach dla domu i inteligentnych rozwiązaniach IT. W rankingu firmy analitycznej
More news about: Hisense
May 22, 2026, 00:58 ET 2026 ASCO Abstract Highlights | Innovent Announces Preliminary PoC data of IBI363 (PD-1/IL-2α-bias bispecific fusion protein) in Combination with Chemotherapy as First-line Treatment for Advanced NSCLC, Showing Encouraging Efficacy Signals and Favorable Safety
the study: 3→1.5 mg/kg dose group (3 mg/kg + PDC in cycle 1, followed by 1.5 mg/kg Q3W + PDC); 1.5 mg/kg dose group (1.5 mg/kg Q3W + PDC); 3 mg/kg dose group (3 mg/kg Q3W + PDC). 2) Study Design and Baseline Characteristics: Focusing on Dose Exploration
More news about: Innovent Biologics
May 21, 2026, 23:52 ET Monport Laser Highlights Expanding Role of Laser Engraver Technology in Small-Business Manufacturing
UV laser marking systems with the launch of its new 6W and 10W UV laser engraving machines designed for cold marking applications across a wider range of materials. Unlike traditional heat-based engraving processes,
More news about: Monport Laser
May 21, 2026, 20:00 ET Kelun-Biotech to Present Two Registrational Studies in the Oral Presentation Session on Non-Small Cell Lung Cancer at ASCO 2026
covering both squamous and non‑squamous histologies, were enrolled and randomized (1:1) to receive sac-TMT (4mg/kg Q2W) plus pembrolizumab (400mg Q6W) or pembrolizumab monotherapy (400mg Q6W). The primary endpoint was progression‑free survival (PFS) assessed by blinded independent central review (BICR),
More news about: Kelun-Biotech
May 21, 2026, 19:49 ET 2026 ASCO Abstract Highlights: Innovent Biologics' IBI363 (PD-1/IL-2α-bias bispecific fusion protein) Demonstrates Robust Survival Benefits in Long-Term Follow-up of PoC Study in Advanced Immunotherapy-Resistant Non-Small Cell Lung Cancer
Among the 58 patients with EGFR wild-type adenoNSCLC, 30 patients received IBI363 at 0.6 mg/kg Q2W or 1 mg/kg Q2W or 1.5 mg/kg Q3W, and 25 patients received IBI363 at 3 mg/kg Q3W. In the 3 mg/kg dose group, the median PFS reached 4.2 (95%CI 3.0, 7.0) months, and the median OS achieved
More news about: Innovent Biologics
May 21, 2026, 17:18 ET INVESTOR DEADLINE TUESDAY: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RGRD Law
Albert655 W. Broadway, Suite 1900, San Diego, CA 92101
More news about: Robbins Geller Rudman & Dowd LLP
May 21, 2026, 17:00 ET Sapience Therapeutics Provides Positive Data Update from Phase 2 Trial of Lucicebtide Plus SOC in Patients with Glioblastoma at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
10.1007/s00432-025-06171-4. PMID: 40455099; PMCID: PMC121301522 Kudo T, Prentzell MT, Mohapatra SR, Sahm F, Zhao Z, Grummt I, Wick W, Opitz CA, Platten M and Green EW (2020) Constitutive Expression of the Immunosuppressive Tryptophan Dioxygenase TDO2 in Glioblastoma Is Driven by the
More news about: Sapience Therapeutics, Inc.
May 21, 2026, 17:00 ET Boehringer Ingelheim's oncology portfolio shows strong promise across multiple cancers at ASCO 2026
Preclinical Models and Patients with HER2-Driven Cancers. Cancer Discov. 2025;15(1):119-138. doi:10.1158/2159-8290.CD-24-03069 Zeng J, Ma W, Young RB, Li T. Targeting HER2 genomic alterations in non-small cell lung cancer. J Natl Cancer Cent. 2021;1(2):58-73. 10 ClinicalTrials.gov.
More news about: Boehringer Ingelheim
May 21, 2026, 17:00 ET Lilly to showcase oncology portfolio across tumor types and treatment modalities at the 2026 American Society of Clinical Oncology Annual Meeting
2016;37(6):7033-7045.Mato AR, Shah NN, Jurczak W, et al. Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study. Lancet. 2021;397(10277):892-901. doi:10.1016/S0140-6736(21)00224-5Hanel W, Epperla N. Emerging therapies in mantle cell lymphoma. J
More news about: Eli Lilly and Company
May 21, 2026, 16:24 ET Tourism in Denver Increased in 2025
more. We are pleased to see 2025 numbers slightly elevated over 2024 and that tourism growth in Denver was in line with national averages," said Richard W. Scharf, President and CEO of Visit Denver. "We are proud that Denver had such a solid showing despite last year's economic headwinds and in spite of
More news about: Visit Denver, The Convention & Visitors Bureau
May 21, 2026, 16:15 ET Webull Reports First Quarter 2026 Financial Results
20-F.ContactsFor [email protected] Media 5W Public RelationsNicholas [email protected](212)
More news about: Webull Corporation
May 21, 2026, 16:04 ET Maryland Stem Cell Research Commission Announces More Than $12.6 Million in Awards to Advance Regenerative Medicine and Opens Applications for Next Funding Cycle
including leading academic institutions such as Johns Hopkins University, University of Maryland, Baltimore, University of Maryland, College Park, Hugo W. Moser Research Institute at Kennedy Krieger, Inc. and Lieber Institute for Brain Development, alongside innovative companies including Theradaptive,
More news about: Maryland Stem Cell Research Commission
May 21, 2026, 16:01 ET Ross Stores Reports Robust First Quarter Sales and Earnings Results, Significantly Exceeding Guidance
Contacts: William W. Sheehan II Connie Kao
More news about: Ross Stores, Inc.
May 21, 2026, 15:15 ET Greenberg Traurig Strengthens SALT Practice with John Ormonde in Washington, D.C.
Joshua W. Johnson in the National Security Group;
More news about: Greenberg Traurig, LLP
May 21, 2026, 15:10 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Babcock & Wilcox Enterprises, Inc. and Certain Officers - BW
products and services that B&W would purportedly provide pursuant to the Power Generation Contract, and that "the ultimate purpose of this deal may be to provide exit liquidity for [BRC]". Taken together, the Wolfpack report's contentions called into question whether B&W was likely to recognize
More news about: Pomerantz LLP
May 21, 2026, 13:35 ET CRAFTSMAN® Launches New V20* ADVANCED™ Batteries to Help DIYers Power Through More Demanding Jobs
www.CRAFTSMAN.com.* 20V MAX* battery, max initial voltage (w/out a workload) is 20 volts. Nominal voltage is 18. † vs. CMCB202 2Ah battery, more runtime based on 10 Amp discharge test, not in application.**
More news about: CRAFTSMAN
May 21, 2026, 12:31 ET CardVault by Tom Brady Announces Second Texas Location in Austin's 2nd Street District
Located at 259 W 3rd Street in the heart of downtown Austin, the new CardVault store will officially open to the public on Wednesday, May 27, offering a premium, immersive
More news about: CardVault by Tom Brady
May 21, 2026, 12:00 ET HDT Bio and UTMB Receive MCDC Innovation Prototype Award for Advancing CCHF Vaccine from Lab to Phase 1 Clinical Trial
necessarily represent the official views of the National Institutes of Health.Effort sponsored by the U.S. Government under Other Transaction number W15QKN-16-9-1002 between the MCDC, and the Government. The US Government is authorized to reproduce and distribute reprints for Governmental purposes, notwithstanding
More news about: HDT Bio Corp.
May 21, 2026, 11:30 ET Cassiar District Polymetallic System Funded For 2026 Drilling Inside Tightening Silver Market
survey scheduled for June, a permit application in process, and three priority drill zones across 37,204 hectares — all dropping into the silver-Pb-Zn-W-In repricing trade now reshaping the broader silver producer universeVANCOUVER, BC, May
More news about: Equity Insider
May 21, 2026, 11:00 ET Finseca Names Jim Hebets the 2026 Peter W. Mullin Visionary Leadership Award Recipient
/PRNewswire/ -- Finseca is proud to announce that Jim Hebets, CEO & Founder of The Hebets Company, has been selected as the 2026 recipient of the Peter W. Mullin Visionary Leadership Award. This prestigious honor recognizes leaders in the financial security profession who exemplify a commitment to excellence,
More news about: Finseca